XOMA Corporation (XOMAP) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown
XOMAP's revenue distribution by segment and geography
By Geography
XOMAP Revenue Analysis (2013–2024)
As of March 4, 2026, XOMA Corporation (XOMAP) generated trailing twelve-month (TTM) revenue of $47.1 million, reflecting exceptional growth of +29.9% year-over-year. The most recent quarter (Q3 2025) recorded $9.4 million in revenue, down 28.8% sequentially.
Looking at the longer-term picture, XOMAP's 5-year compound annual growth rate (CAGR) stands at +9.2%, indicating steady revenue expansion. The company achieved its highest annual revenue of $55.4 million in 2015.
When compared to Healthcare sector peers including RPRX (+3.7% YoY), LGND (+64.8% YoY), and INVA (+14.5% YoY), XOMAP has underperformed the peer group in terms of revenue growth. Compare XOMAP vs RPRX →
Peer Comparison
Compare XOMAP's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| XOMAPCurrent | $47M | +29.9% | +9.2% | -140.3% | |
 RPRX | $2.4B | +3.7% | +2.3% | 65.6% | |
 LGND | $167M | +64.8% | +6.8% | -13.5% | |
 INVA | $425M | +14.5% | +4.8% | 38.5% | |
 BTX | $41M | - | - | 87.7% | |
 XOMA | $28M | +191.2% | +9.2% | -140.3% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $28.5M | +498.7% | $28.3M | 99.3% | $-39,976,000 | -140.3% |
| 2023 | $4.8M | -21.1% | $4.6M | 97.0% | $-41,848,000 | -879.5% |
| 2022 | $6.0M | -84.2% | $5.8M | 95.5% | $-17,414,000 | -288.9% |
| 2021 | $38.2M | +29.9% | $38.0M | 99.6% | $17.5M | 45.9% |
| 2020 | $29.4M | +60.0% | $29.2M | 99.4% | $12.4M | 42.3% |
| 2019 | $18.4M | +246.7% | $17.1M | 93.2% | $-3,885,000 | -21.1% |
| 2018 | $5.3M | -89.9% | $3.6M | 68.3% | $-16,857,000 | -318.1% |
| 2017 | $52.7M | +847.0% | $44.8M | 85.1% | $17.0M | 32.3% |
| 2016 | $5.6M | -90.0% | $4.2M | 74.8% | $-61,558,000 | -1106.4% |
| 2015 | $55.4M | +193.9% | $34.7M | 62.7% | $-39,724,000 | -71.6% |
See XOMAP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XOMAP Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare XOMAP vs AGIO
See how XOMAP stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is XOMAP's revenue growth accelerating or slowing?
XOMAP revenue is accelerating at +29.9% year-over-year, exceeding the 5-year CAGR of +9.2%. TTM revenue reached $47M. Growth momentum has increased versus prior periods.
What is XOMAP's long-term revenue growth rate?
XOMA Corporation's 5-year revenue CAGR of +9.2% reflects the sustained expansion pattern. Current YoY growth of +29.9% is above this long-term average.
How is XOMAP's revenue distributed by segment?
XOMAP reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.